Table 4.
No. of episodes (%) |
||||||
---|---|---|---|---|---|---|
GP |
XP |
|||||
Grade 1-2 | Grade 3-4 | Total | Grade 1-2 | Grade 3-4 | Total | |
Hematologic | ||||||
Anemia | 8 (29.6) | 6 (22.2) | 14 (51.8) | 1 (2.8) | 0 | 1 (2.8) |
Neutropenia | 2 (7.4) | 2 (7.4) | 4 (14.8) | 6 (16.7) | 2 (5.6) | 8 (22.2) |
Thrombocytopenia | 7 (25.9) | 4 (14.8) | 11 (40.7) | 4 (11.1) | 4 (11.1) | 8 (22.2) |
Non-hematologic | ||||||
Nausea | 2 (7.4) | 1 (3.7) | 3(11.1) | 0 | 2 (5.6) | 2 (5.6) |
Vomiting | 2 (7.4) | 1 (3.7) | 3(11.1) | 1 (2.8) | 1 (2.8) | 2 (5.6) |
Anorexia | 2 (7.4) | 1 (3.7) | 3 (11.1) | 1 (2.8) | 1 (2.8) | 2 (5.6) |
Asthenia | 3 (11.1) | 1 (3.7) | 4 (14.8) | 0 | 3 (8.3) | 3 (8.3) |
Stomatitis | 0 | 0 | 0 | 1 (2.8) | 1 (2.8) | 2 (5.6) |
Diarrhea | 0 | 0 | 0 | 0 | 0 | 0 |
Neuropathy | 0 | 0 | 0 | 0 | 0 | 0 |
Nephropathy | 0 | 0 | 0 | 0 | 0 | 0 |
Hand-foot syndrome | 0 | 0 | 0 | 1 (2.8) | 3 (8.3) | 4 (11.1) |
Infection | 0 | 0 | 0 | 0 | 0 | 0 |
GP, gemcitabine-cisplatin; XP, capecitabine-cisplatin.